News
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
5 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Tempest Announces Publication Of Data From Phase 1 Trial Of TPST-1120 In Patients With Advanced Solid Tumors In Journal Of Cancer Research Communications
4 Apr 24
Biotech, News, General
Tempest FY23 EPS $(1.91) Vs $(3.09) YoY; Ended The Year With $39.2M In Cash And Cash Equivalents
19 Mar 24
Earnings, News
Scotiabank Initiates Coverage On Tempest Therapeutics with Sector Outperform Rating, Announces Price Target of $13
14 Mar 24
News, Price Target, Initiation, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Tempest Therapeutics, Maintains $47 Price Target
12 Mar 24
News, Price Target, Analyst Ratings
Tempest Presents New Data At The SITC 2024 Spring Scientific Meeting Supporting Potent Anti-Tumor Activity Of TPST-1120 In Multiple Cancer Types
12 Mar 24
Biotech, News, General
Jefferies Initiates Coverage On Tempest Therapeutics with Buy Rating, Announces Price Target of $15
8 Feb 24
News, Price Target, Initiation, Analyst Ratings
Tempest Therapeutics Shares Up 19% Premarket. A Press Release Earlier Announced A Presentation On Its Liver Cancer Treatment At ASCO Annual Meeting 2024
30 Jan 24
News
Press releases
Glancy Prongay & Murray LLP Announces Investigation of Tempest Therapeutics, Inc. (TPST)
14 Mar 24
Press Releases
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2 Feb 24
Markets, Press Releases
Thinking about buying stock in Agape ATP, Tempest Therapeutics, Nu Holdings, Bristol-Myers Squibb, or Petros Pharmaceuticals?
30 Jan 24
Opinion, Press Releases
Tempest Therapeutics Announces Groundbreaking Advances in Liver Cancer Treatment, Showcasing Exceptional Efficacy and Safety Data at ASCO Annual Meeting 2024
30 Jan 24
News, Press Releases